Shaanxi Micot Pharmaceutical Technology Co., Ltd. Class H
2335.HK
Get informed when a big investor buys or sells
+ FollowMarket Cap$6.18B
Close$
Share Statistics
| Market cap | $6.18 Billion |
|---|---|
| Enterprise Value | - |
| Dividend Yield | $- (NaN%) |
| Earnings per Share | $- |
| Beta | -0.13 |
| Outstanding Shares | - |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 28, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Shaanxi Micot Pharmaceutical Technology Co., Ltd. Class H
121 employees
CEO: Bing Wang Shaanxi Mycotech Pharmaceutical Technology Co., Ltd. operates as a platform-based biotechnology company dedicated to accelerating the global innovation and development of next-generation bi-multi-specific peptide drugs. Its products incl...